Nicolas Forraz
Scientific committee
Dr Forraz is Chief Executive officer of CTIBiotech in charge of business development, industrial operations and relations to investors and financial institutions. He has extensive expertise stem cells, regenerative medicine and 3D Tissue and with Professor Colin McGuckin was part of the team who created the world’s first artificial hepatic-like liver tissue and neural cells from human umbilical cord blood. With an interest in cross-developing clinical research for business-generating technologies, Dr Forraz has extensive experience in negotiation, business creation and operations. Dr Forraz has spear-headed the 43 Million Euro consortium generation of the IMODI Cancer project, the largest cancer research project of France. Winner of several international business plan competitions.
Dr Forraz served between 2019 and 2022 as the President of Cosmet’in Lyon Skin Science, a not-for-profit professional organization linking researchers, interprofessional organizations and industry to share the latest scientific knowledges in dermocosmetology and promote excellence and expertise in cosmetology.Dr Forraz completed his PhD in 2003 at Kingston University and St George’s Hospital Medical School, University of London, UK in Tissue Engineering and Regenerative Medicine. From 2003 to 2004, Dr Forraz carried out a postdoctoral research project at St George’s Hospital Medical School, London, UK, on cancer stem cells. He then worked as a Senior Researcher in the Stem Cell Therapy Programme to promote research links and business activities in the field of Regenerative Medicine, Tissue Bio-Engineering, Space Medicine and Oncology with Research Institutions in Texas, USA. In 2005, he was appointed Senior Research Associate and Business Development Manager in Professor McGuckin's Regenerative Medicine research group at Newcastle University, UK and co-founded CTIBIOTECH in 2009